[ad_1]
- BioLife Solutions (NASDAQ:BLFS) on Monday announced the acquisition of privately-held PanTHERA CryoSolutions, a developer of novel cryopreservation solutions based on proprietary Ice Recrystallization Inhibitor (“IRI”) technology.
- BioLife said it is purchasing the 90% of PanTHERA common shares it does not own for $9.3
[ad_2]
Source link
